JP2003012516A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003012516A5 JP2003012516A5 JP2001391481A JP2001391481A JP2003012516A5 JP 2003012516 A5 JP2003012516 A5 JP 2003012516A5 JP 2001391481 A JP2001391481 A JP 2001391481A JP 2001391481 A JP2001391481 A JP 2001391481A JP 2003012516 A5 JP2003012516 A5 JP 2003012516A5
- Authority
- JP
- Japan
- Prior art keywords
- calmodulin
- calcium
- kinase inhibitor
- dependent kinase
- hydrogen atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001391481A JP4153693B2 (ja) | 2001-04-25 | 2001-12-25 | 新規なCaMKK阻害剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001-127524 | 2001-04-25 | ||
| JP2001127524 | 2001-04-25 | ||
| JP2001391481A JP4153693B2 (ja) | 2001-04-25 | 2001-12-25 | 新規なCaMKK阻害剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003012516A JP2003012516A (ja) | 2003-01-15 |
| JP2003012516A5 true JP2003012516A5 (2) | 2005-07-14 |
| JP4153693B2 JP4153693B2 (ja) | 2008-09-24 |
Family
ID=26614177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001391481A Expired - Fee Related JP4153693B2 (ja) | 2001-04-25 | 2001-12-25 | 新規なCaMKK阻害剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4153693B2 (2) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8207185B2 (en) | 2006-10-12 | 2012-06-26 | Duke University | CaMKKβ as a target for treating obesity |
| US20130253035A1 (en) | 2010-08-16 | 2013-09-26 | Duke University | Camkk-beta as a target for treating cancer |
| RU2670218C2 (ru) * | 2013-08-05 | 2018-10-19 | Басф Се | Цианированные нафталинбензимидазольные соединения |
| WO2020041344A1 (en) * | 2018-08-20 | 2020-02-27 | Duke University | Methods and compositions for drugs to treat ophthalmic diseases |
-
2001
- 2001-12-25 JP JP2001391481A patent/JP4153693B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003531118A5 (2) | ||
| JP2004516314A5 (2) | ||
| CA2379560A1 (en) | Purine derivatives inhibitors of tyrosine protein kinase syk | |
| JP2010501478A5 (2) | ||
| GEP20074033B (en) | Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use | |
| PL367618A1 (en) | 5-halo-tryptamine derivatives used as ligands of the 5-ht6 and/or 5-ht 7 serotonin receptors | |
| CA2432085A1 (en) | Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands | |
| JP2003503449A5 (2) | ||
| JP2002513793A5 (2) | ||
| JP2002525323A5 (2) | ||
| WO2001064645A3 (en) | Derivatives of quinoline as alpha-2 antagonists | |
| AP2002002664A0 (en) | Cyclohexylamine derivative as subtype selective NMDA receptor antagonists. | |
| NO20040881L (no) | Orale antidiabetes midler. | |
| RU2002100058A (ru) | Кристаллические производные 1-метилкарбапенема | |
| JP2000159790A5 (2) | ||
| PT992509E (pt) | Novos derivados macrolidos | |
| JP2002506864A5 (2) | ||
| WO2005033066A3 (fr) | Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique sanofi-synthelabo | |
| DK1204658T3 (da) | Benzofurylpiperazin-serotoninagonister | |
| ZA200704584B (en) | New 3-Phenylpropionic acid derivatives for the treatment of diabetes | |
| MXPA04005077A (es) | Derivados de benzotiazol. | |
| CA2088702A1 (en) | Aminobenzoic acid derivatives | |
| CA2362211A1 (en) | Benzamide derivatives and medicament containing the same | |
| AU5125798A (en) | Novel n-benzenesulphonyl-l-proline derivatives, method for preparing and therapeutic use | |
| AU2003263455A1 (en) | Pyrazole amides for treating hiv infections |